153
Views
33
CrossRef citations to date
0
Altmetric
Research Article

5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours

Pages 625-638 | Published online: 29 Sep 2008

References

  • AMMIRATI, M., VICK, N., LIAO, Y., CIRIC, I., and MIKHAEL, M., 1987, Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery, 21, 201–206.
  • BAZILE, D., PRUDHOMME, C., BASSOULLET, M. T., MARLARD, M., SPENLEHAUER, G., and VEILLARD, M., 1995, Stealth Me-PEG-PLA nanoparticles avoid uptake by the mononuclear phagocyte systems. Journal of Pharmaceutical Science, 84,493–498.
  • BECOUARN, Y., BRUNET, R., and BARBE-GASTON, C., 1989, Fluorouracil, deoxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary. European Journal of Cancer and Clinical Oncology, 25, 861–865.
  • BODMEIER, R., OH, K. H., and CHEN, H., 1989, The effect of the addition of low molecular weight poly (HL-lactide) on drug release from biodegradable poly (HL-lactide) drug delivery systems. International Journal of Pharmaceutics, 51, 1–8.
  • BOISDRON-CELLE, M., MENEI, P. H., and BENOIT, J. P., 1995, Preparation and characteriza-tion of 5-flurouracil-loaded microp articles as biodegradable anticancer drug carriers. Journal of Pharmacology, 47, 108–114.
  • BREM, H., WALTER, K. A., and LANGER, R., 1993, Polymers as controlled drug delivery devices for the treatment of malignant brain tumours. European Journal of Pharmaceutics and Biopharmaceutics, 39, 2–7.
  • CARELLI, V., and DicoLo, G., 1983, Effect of different water soluble additives on water sorption into silicone rubber. Journal of Pharmaceutical Science, 72, 316–317. CHANDY, T., and SHARMA, C. P., 1992, Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro stueies. Biomaterials, 13, 949–952.
  • CHANDY, T., and SHARMA, C. P., 1996, Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads. Biomaterials, 17, 61–66.
  • CHANDY, T., MOORADIAN, D. L., and RAO, G. H. R., 1998, Chitosan/polyethylene glycol-alginate microcapsules for oral delivery of hiridin. Journal of Applied Polymer Science, 70, 2143–2153.
  • CLELAND, J. L., 1997, Protein delivery from biodegradable microspheres. Pharmaceutical Biotechnology, 10, 1–43.
  • COOPER, J. S., BOROK, T. L., RANSOHOFF, J., and CARELLA, R., 1982, Malignant glioma—results of combined modality therapy. JA/V/A, 248, 62–65.
  • FRAZZA, E. J., and Sul-muff, E. E., 1971, New absorbable suture. Journal of Biomedical Materials Research Symposium, 1, 43–58.
  • GARFIELD, J., 1980, Surgery of cerebral gliomas. In Brain Tumours, Scientific Basis, Clinical Investigations, and Current Therapy, edited by D. G. T. Thomas and D. T. Graham (London: Butterworths), pp. 301–321.
  • GREEN, S. B., BYAR, D. P., WALKER, M. D., PISTENMAA, D. A., ALEXANDER, E., JR, BATZDORF, U., BROOKS, W. H., HUNT, W. E., MEALEY, J., ODOM, G. L., PAOLETTI, P., RANSOHOFF, J., II, ROBERTSON, I. T., SELKER, R. J., SHAPIRO, W. R., SMITH, K. R., WILSON, C. B., and STRIKE, T. A., 1983, Comparison of carmustine, procarbazine and high-dose methyl prednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treatment Reports, 67, 121–132.
  • GREF, R., MINIMITAKE, Y., PERACCHIA, M. T., TRUBETSKOY, V., TORCHILIN, V., and LANGER, R., 1994, Biodegradable long-circulating nanospheres. Science, 263, 1600-1603. HARI, P. R., CHANDY, T., and SHARMA, C. P., 1996, Chitosan/calcium alginate beads for oral delivery of insulin. Journal of Applied Polymer Science, 59, 1795–1801.
  • HELLER, J., 1980, Controlled release of biologically active compounds from bioerodible polymers. Biomaterials, 1, 51–57.
  • KORNBLITH, P. L., and WALKER, M., 1988, Chemotheraphy for malignant gliomas. Journal of Neurosurgery, 68, 1–17.
  • LEE, T. K., Soxouosm, T. D., and ROGER, G. P., 1981, Serum albumin beads, an injectable, biodegradable system for the sustained release of drugs. Science, 213, 233–235.
  • Lim, L. Y., and WAN, L. S. C., 1998, Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique. Journal of Microencapsula-tion, 3, 319–333.
  • LIN, S. Y., CHEN, K. S., and TENG, H.-H., 1998, Functionality of protective colloids affecting the formation, size uniformity and morphology of drug-free polylactic acid microspheres. Journal of Microencapsulation, 15, 383–390.
  • NEUWELT, E. A., BARNETT, P. A., GLASBERG, M., and FRENKEL, E. P., 1983, Pharmacology and neurotoxicity of cis-diammine dichloroplatinum, bleomycin, 5-fluorouracil and cyclophosphamide administration following osmotid blood-brain barrier modifica-tion. Cancer Research, 43, 5278–5285.
  • NIHANT, N., GRANDFILS, C., JERO1VIE, R., and TEYSSIE, P., 1995, Microencapsulation by coacervation of poly(lactic-co-glycolide) IV. Effect of the processing parameters on coacervation and encapsulation. Journal of Controlled Release, 35, 117–125.
  • NISHIMURA, K., NISHIMURA, S., SEO, H., Nisin, N., TOKURA, S., and AZUMA, I., 1986, Macrophage activation with multi-porous beads prepared from partially deacetylated chitin. Journal of Biomedical Materials Research, 20, 1359–1372.
  • NIWA, T., TAKEUCHI, H., HINO, T., KUNOU, N., and KAWASHIMA, Y., 1993, Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with DL-lactide/ glycilide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behaviour. Journal of Controlled Release, 25, 89–98.
  • PITT, C. G., GRATZI, M. M., JEFFCOAT, A. R., ZWEIDINGER, R., and SCHINDLER, A., 1979, Sustained drug delivery systems. II, Factors affecting release rates from poly (-caprolactone) and related biodegradable polyester. Journal Of Pharmaceutical Science, 68, 1534–1538.
  • QUELLEC, P., GREF, R., PERRIN, L., DELLACHERIE, E., SOMMER, F., VERBAVATZ, J. M., and ALONSO, M. J., 1998, Protein encapsulation within polyethylene glycol-coated nanospheres. I, Physicochemical characterization. Journal of Biomedical Materials Research, 42, 45–54.
  • Ruiz, J. M., and BENOIT, J. P., 1991, In vivo peptide release from poly(DL-lactic acid-co-glycolic acid) copolymer 50/50 microspheres. Journal of Controlled Release, 16, 177–186.
  • SONG, C. X., LABHASETWAR, V., MURPHY, H., Qu, X., HUMPHREY, W. R., SHEBUSKI, R., LEVY, R. J., 1997, Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. Journal of Controlled Release, 43, 197–212.
  • THACHARODI, D., and RAO, K. P., 1995, Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propanolol hydrochloride. Biomaterials, 16, 145–148.
  • UPADRASHTA, S. M., KATIKANENI, P. R., and NUESSLE, N. 0., 1992, Chitosan as a tablet binder. Drug Development and Industrial Pharmacy, 18, 1701–1708.
  • WALKER, R. W., and POSNER, J. B., 1984, Central nervous system neoplasms. Current Neurology, 5, 285–322.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.